TabletsClinical Overview
Fexofenadine Hydrochloride Tablets (120mg, 180mg) and Suspension (30mg/5ml) is a pure, non-sedating second-generation H1-receptor antagonist on the WHO Model List of Essential Medicines. It is the active carboxylic acid metabolite of terfenadine, but completely lacks terfenadine's cardiotoxicity (does NOT block cardiac HERG potassium channels or cause QT prolongation/Torsades de Pointes). Does not cross the blood-brain barrier. Indicated for relief of symptoms associated with seasonal allergic rhinitis (120 mg once daily) and chronic idiopathic urticaria (180 mg once daily).
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally once daily with water, with or without food. Do NOT take with fruit juices (grapefruit, orange, apple), which inhibit intestinal OATP1A2 uptake transporters and slash bioavailability by >35%. Do NOT take within 2 hours of aluminum- or magnesium-containing antacids.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Headache, dizziness, nausea, fatigue, dyspepsia. Completely devoid of sedative drowsiness or anticholinergic effects.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Over-The-Counter antihistamine. Zero sedative effect; ideal for daytime use and safety-sensitive occupations (driving, operating machinery). Take with plain water only; avoid fruit juices. Safe cardiovascular profile.
Over-The-Counter (OTC)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, pulmonological diagnosis, or respiratory management recommendations. Inhalation therapies and allergy medications should be used strictly under the guidance of a qualified pulmonologist or registered medical practitioner.
Fexofenadine Tablets 180 mg
Fexofenadine Hydrochloride Tablets (120mg, 180mg) and Suspension (30mg/5ml) is a pure, non-sedating second-generation H1-receptor antagonist on the WHO Model List of Essential Medicines. It is the active carboxylic acid metabolite of terfenadine, but completely lacks terfenadine's cardiotoxicity (does NOT block cardiac HERG potassium channels or cause QT prolongation/Torsades de Pointes). Does not cross the blood-brain barrier. Indicated for relief of symptoms associated with seasonal allergic rhinitis (120 mg once daily) and chronic idiopathic urticaria (180 mg once daily).
Montelukast Sodium 10mg + Fexofenadine Hydrochloride 120 mg Tablets
Montelukast Sodium (10mg) and Fexofenadine Hydrochloride (120mg Tablets, Suspension) is a non-sedating dual antiallergic combination. Fexofenadine is a pure second-generation H1-receptor antagonist that does not cross the blood-brain barrier (completely non-sedating), while montelukast blocks cysteinyl leukotriene CysLT1 receptors. Indicated for relief of symptoms associated with allergic rhinitis (sneezing, runny nose, itchy/watery eyes, nasal congestion) in patients needing daytime alertness.
Fexofenadine Hydrochloride Suspension (30mg/5ml)
Fexofenadine Hydrochloride Tablets (120mg, 180mg) and Suspension (30mg/5ml) is a pure, non-sedating second-generation H1-receptor antagonist on the WHO Model List of Essential Medicines. It is the active carboxylic acid metabolite of terfenadine, but completely lacks terfenadine's cardiotoxicity (does NOT block cardiac HERG potassium channels or cause QT prolongation/Torsades de Pointes). Does not cross the blood-brain barrier. Indicated for relief of symptoms associated with seasonal allergic rhinitis (120 mg once daily) and chronic idiopathic urticaria (180 mg once daily).
Montelukast Sodium 4mg + Fexofenadine 60mg per 5ml Suspension
Montelukast Sodium (10mg) and Fexofenadine Hydrochloride (120mg Tablets, Suspension) is a non-sedating dual antiallergic combination. Fexofenadine is a pure second-generation H1-receptor antagonist that does not cross the blood-brain barrier (completely non-sedating), while montelukast blocks cysteinyl leukotriene CysLT1 receptors. Indicated for relief of symptoms associated with allergic rhinitis (sneezing, runny nose, itchy/watery eyes, nasal congestion) in patients needing daytime alertness.